• Home
  • Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer.

Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer.

Author List
Sun X, Kumbier K, Gayathri S, Steri V, Wu LF, Altschuler SJ
Publication
Cancer research communications
Publication ID (Profile URL)
https://researcherprofiles.org/profile/570244252
Publication Year
2025
PubMed ID
39699269
Publication Title
Sun X, Kumbier K, Gayathri S, Steri V, Wu LF, Altschuler SJ. Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer. Cancer Res Commun. 2025 Jan 01; 5(1):119-127.